INSEEGO CORP
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
INSG$4.22+8.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except par value, share and per share data)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $39,596 | $2,409 |
| Accounts receivable, net of allowance for expected credit losses of $123 and $617, respectively | 13,803 | 18,202 |
| Inventories | 13,575 | 20,555 |
| Prepaid expenses and other | 5,926 | 4,937 |
| Current assets held for sale | — | 12,123 |
| Total current assets | 72,900 | 58,226 |
| Property, plant and equipment, net of accumulated depreciation of $28,897 and $27,513, respectively | 1,102 | 2,389 |
| Intangible assets, net of accumulated amortization of $33,558 and $31,444, respectively | 18,747 | 25,718 |
| Goodwill | 3,949 | 3,949 |
| Operating lease right-of-use assets | 2,855 | 4,022 |
| Other assets | 446 | 1,256 |
| Non-current assets held for sale | — | 26,237 |
| Total assets | $99,999 | $121,797 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $18,433 | $23,408 |
| Accrued expenses and other current liabilities | 30,133 | 21,049 |
| 2025 Convertible Notes, net | 14,905 | — |
| Revolving credit facility, net | — | 4,094 |
| Current liabilities held for sale | — | 7,360 |
| Total current liabilities | 63,471 | 55,911 |
| Long-term liabilities: | ||
| 2025 Convertible Notes, net | — | 159,912 |
| Operating lease liabilities | 2,627 | 3,972 |
| Deferred tax liabilities, net | 174 | 112 |
| 2029 Senior Secured Notes, net | 41,830 | — |
| Other long-term liabilities | 4,755 | 2,351 |
| Non-current liabilities held for sale | — | 1,644 |
| Total liabilities | 112,857 | 223,902 |
| Commitments and Contingencies (Note 11.) | ||
| Stockholders’ deficit: | ||
| Preferred stock, par value $0.001; 2,000,000 shares authorized: | ||
| Series E Preferred stock, par value $0.001; 39,500 shares designated, 25,000 shares issued and outstanding as of December 31, 2024 and December 31, 2023, aggregate liquidation preference of $38,392,444 as of December 31, 2024 | — | — |
| Common stock, par value $0.001; 150,000,000 shares authorized, 14,990,712 and 11,878,557 shares issued and outstanding as of December 31, 2024 and December 31, 2023 (*), respectively | 15 | 12 |
| Additional paid-in capital (*) | 892,534 | 810,138 |
| Accumulated other comprehensive loss | 218 | (5,327) |
| Accumulated deficit | (905,625) | (906,928) |
| Total stockholders’ deficit | (12,858) | (102,105) |
| Total liabilities and stockholders’ deficit | $99,999 | $121,797 |
(*)Adjusted retroactively for reverse stock split that occurred on January 24, 2024, see Note 1
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.